Cigna Group $CI Shares Sold by Roman Butler Fullerton & Co.

Roman Butler Fullerton & Co. lowered its stake in Cigna Group (NYSE:CIFree Report) by 19.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,455 shares of the health services provider’s stock after selling 3,318 shares during the quarter. Cigna Group comprises about 1.0% of Roman Butler Fullerton & Co.’s portfolio, making the stock its 24th biggest holding. Roman Butler Fullerton & Co.’s holdings in Cigna Group were worth $4,097,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Norges Bank acquired a new stake in shares of Cigna Group in the fourth quarter valued at $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its position in Cigna Group by 13,333.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after purchasing an additional 3,141,844 shares in the last quarter. Dodge & Cox grew its stake in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares in the last quarter. Boston Partners grew its position in Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after purchasing an additional 1,243,056 shares in the last quarter. Finally, GQG Partners LLC increased its stake in shares of Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after acquiring an additional 972,302 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 0.1%

NYSE CI opened at $282.24 on Monday. The stock has a market capitalization of $74.58 billion, a P/E ratio of 11.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a fifty day moving average of $286.02 and a 200-day moving average of $281.28.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the firm posted $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $336.00 to $307.00 in a report on Tuesday, August 4th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. The Goldman Sachs Group upped their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Mizuho boosted their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

View Our Latest Research Report on CI

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.